Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Delcath Systems, Inc. - Common Stock (NQ:DCTH)

16.86 -0.24 (-1.37%)
Streaming Delayed Price Updated: 10:50 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 71,157
Open 16.76
Bid (Size) 16.80 (2)
Ask (Size) 16.92 (6)
Prev. Close 17.10
Today's Range 16.34 - 16.93
52wk Range 6.330 - 17.15
Shares Outstanding 7,906,728
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
From Delcath Systems, Inc.
Via Business Wire
Checking if DELCATH SYSTEMS INC (NASDAQ:DCTH) meets Minervini’s stock selection rules
A fundamental and technical analysis of (NASDAQ:DCTH): Why the high growth investor may take a look at DELCATH SYSTEMS INC (NASDAQ:DCTH). 
Via Chartmill

Performance

YTD
+33.7%
+33.7%
1 Month
+48.7%
+48.7%
3 Month
+3.0%
+3.0%
6 Month
+73.2%
+73.2%
1 Year
+110.0%
+110.0%

More News

Read More
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Analyst Expectations For Delcath Systems's Future
Via Benzinga
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
From Delcath Systems, Inc.
Via Business Wire
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems to Host First Quarter 2025 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
From Delcath Systems, Inc.
Via Business Wire
Beta Bionics Announces Board Appointment of Gerard Michel
From Beta Bionics, Inc.
Via GlobeNewswire
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Earnings Scheduled For March 6, 2025
Via Benzinga
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
From Delcath Systems, Inc.
Via Business Wire
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises
From Delcath Systems, Inc.
Via Business Wire
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
From Delcath Systems, Inc.
Via Business Wire

Frequently Asked Questions

Is Delcath Systems, Inc. - Common Stock publicly traded?
Yes, Delcath Systems, Inc. - Common Stock is publicly traded.
What exchange does Delcath Systems, Inc. - Common Stock trade on?
Delcath Systems, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Delcath Systems, Inc. - Common Stock?
The ticker symbol for Delcath Systems, Inc. - Common Stock is DCTH on the Nasdaq Stock Market
What is the current price of Delcath Systems, Inc. - Common Stock?
The current price of Delcath Systems, Inc. - Common Stock is 16.86
When was Delcath Systems, Inc. - Common Stock last traded?
The last trade of Delcath Systems, Inc. - Common Stock was at 05/19/25 10:50 AM ET
What is the market capitalization of Delcath Systems, Inc. - Common Stock?
The market capitalization of Delcath Systems, Inc. - Common Stock is 133.35M
How many shares of Delcath Systems, Inc. - Common Stock are outstanding?
Delcath Systems, Inc. - Common Stock has 133M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.